Ken ChengPresident

  • Dongguan Shun Cheng Computer Enteprise Corporation Director of Board
  • Solytech Enteprise Corporation President
  • Experiences in R&D and manufacturing departments of electronic components industry management for over 30 years.

Sean Chen Ph.D.General Manager

  • MS/Ph.D., Neuroscience, College of Medicine, Ohio State University, Columbus, USA
  • Research Fellow, Whitehead Institute for Biomedical Research, MIT, Boston, USA
  • Department Head, R&D, Genovate Biotechnology Co., Ltd. Taiwan
  • Founder/Board Director/General Manager, Transwell Biotechnology Co., Ltd. Taiwan
  • Founder/Board Director/GM, Capstone Biotek Inc., Taipei
  • Experiences in Drug development for over 30 years.

Cheng-Wen Lin Ph.D.Chief Scientific Officer

  • Ph.D., Biomedical Engineering, Durham, NC, Duke University
  • Postdoctoral Fellow, Durham, NC, Duke University Eye Center
  • Director of Research (Executive level), Aerie Pharmaceuticals, Inc. (now Alcon)
  • Adjunct Assistant Professor, School of Pharmacy, Morgantown, WV, West Virginia University
  • Chief Scientific Officer, Perfuse Therapeutics, Inc.
  • Experiences in ocular drug research and development for over 15 years
  • Discovered and developed two marketed products (Rhopressa® & Rocklatan®)

Akaphot Thongmee (Mark), M.D.,Chief Medical Officer

  • Ph.D. candidate, Faculty of Medicine, Chiang Mai University, Thailand (Expect graduation in 2024)
  • Global Head, Medical Affairs, Grand Pacific Contract Research Organization (GPCRO)
  • SEA Regional Head, Medical Affairs at Docquity Thailand Ltd.
  • Medical Affairs Head (TH&VN) at Allergan Ltd.
  • Country Medical Lead at Amgen (Thailand) Ltd.
  • Medical advisor, Department of Oncology, Novartis International AG.
  • Medical advisor/Product physician, Innovative oncology portfolio, Pfizer (Thai) Ltd.
  • Medical advisor, oncology/cardiovascular/metabolic/respiratory portfolio, Boehringer Ingelheim (Thai) Ltd.
  • Experiences in medical advisor at multinational pharmaceutical companies for over 10 years

Simon HuangExecutive Vice President

  • NYIT M.B.A.
  • Barits Securities Corporation Researcher
  • Solytech Enteprise Corporation Independent President
  • Taipei Biotech Association Supervisor
  • Professional experiences in clinical trail over 6 years
  • Professional experiences (including the experiences of the securities industry and the investment company) in financial industry and capital market for over 20 years.

Amy ChenOffice of General Affairs Director& Chief Financial Officer

  • Royal Roads University M.B.A. in Executive Management
  • Wayi International Digital Entertainment Co.,Ltd.. Manager
  • Professional experiences in financial management and fund allocation for over 25 years.

Evelyn WangBusiness Development& Management Department Director

  • National Chung Cheng University M.B.A.
  • PWC Taiwan Auditor
  • Taipei Fubon Commercial  Senior Specialist
  • Experiences in financial industry, accounting field, and research on business management for over 10 years.